Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

D. Hoelzer(Oak Ridge National Laboratory), Christian Buske(University Hospital Ulm), Hervé Dombret(University of London Institute in Paris), Renato Bassan(Pittini Group (Italy)), Adele K. Fielding(New York Blood Center), Josep‐María Ribera(Universitat Autònoma de Barcelona)

Annals of Oncology

April 8, 2016

10.1093/annonc/mdw025

Cited by 457

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

|Blood|2016|5.9k

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

|Blood|2009|3.4k

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

|Blood|2022|3.1k

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

|Blood|2022|2.8k

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

|The Lancet Oncology|2014|1.3k